Munich, 01.06.2018 – Quarton International advised IK Investment Partners (“IK”) on the acquisition of Klingel medical metal GmbH (“KLINGEL”), a leading supplier of medical technology applications.
Quarton acted as both M&A and Debt Advisor for IK. In addition to the IPO of Medartis AG and the sale of SMB to Groupe Marle, this transaction underlines Quarton’s extraordinary expertise in the field of MedTech.
IK Investment Partners (“IK”) is a Pan-European private equity firm focused on investments in the Nordics, DACH region, France, and Benelux. Since 1989, IK has raised more than €9.5 billion of capital and invested in over 115 European companies. IK funds support companies with strong underlying potential, partnering with management teams and investors to create robust, well-positioned businesses with excellent long-term prospects.
For more than 30 years, KLINGEL medical metal GmbH has been one of the leading European precision technology companies with a strategic focus on medical technology industries. Employing over 300 people, KLINGEL medical metal GmbH specialises in the precision processing of materials with low machinability, such as titanium and high-grade stainless steel. KLINGEL´s high precision components go into various orthopaedic, cardiovascular and dental implants as well as instruments for endoscopy and robotic surgery.
December 20, 2018
Quarton International advises evitria in its sale to AFINUM and SHS
To subscribe to our Newsletter, please use the following link.